BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31015770)

  • 1. Barriers and facilitators of follow-up among women with precancerous lesions of the cervix in Cameroon: a qualitative pilot study.
    Manga S; Kiyang E; DeMarco RF
    Int J Womens Health; 2019; 11():229-239. PubMed ID: 31015770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with adherence to post-treatment follow-up among a cohort of women with acetic acid/Lugol's iodine positive lesions of the cervix in Cameroon: A retrospective cohort study.
    Manga SM; Nkfusai JF; Nulah KL; Manjuh F; Fokom-Domgue J; Ye Y
    Gynecol Oncol Rep; 2023 Oct; 49():101269. PubMed ID: 37727369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa.
    Dietrich JJ; Hornschuh S; Khunwane M; Makhale LM; Otwombe K; Morgan C; Huang Y; Lemos M; Lazarus E; Kublin JG; Gray GE; Laher F; Andrasik M;
    PLoS One; 2020; 15(4):e0231086. PubMed ID: 32324753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.
    Datchoua Moukam AM; Embolo Owono MS; Kenfack B; Vassilakos P; Petignat P; Sormani J; Schmidt NC
    Reprod Health; 2021 Jul; 18(1):147. PubMed ID: 34243778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "ARVs is for HIV and cream is for HPV or precancer:" Women's Perceptions and Perceived Acceptability of Self-Administered Topical Therapies for Cervical Precancer Treatment: A Qualitative Study from Kenya.
    Mungo C; Kachoria AG; Adoyo E; Zulu G; Goraya SK; Omoto J; Osongo C; Ferrari RM
    medRxiv; 2024 Mar; ():. PubMed ID: 38559146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of Self-Sampling for Cervical Cancer Screening Among Women Living With HIV and HIV-Negative Women in LimbĂ©, Cameroon.
    Pierz AJ; Ajeh R; Fuhngwa N; Nasah J; Dzudie A; Nkeng R; Anastos KM; Castle PE; Adedimeji A
    Front Reprod Health; 2020; 2():561202. PubMed ID: 36304705
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors Associated with Treatment Uptake Among Women with Acetic Acid/Lugol's Iodine Positive Lesions of the Cervix in Cameroon.
    Manga SM; Shi L; Welty TK; DeMarco RF; Aronowitz T
    Int J Womens Health; 2020; 12():495-504. PubMed ID: 32612397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
    Moodley J; Constant D; Botha MH; van der Merwe FH; Edwards A; Momberg M
    BMC Womens Health; 2019 Jan; 19(1):2. PubMed ID: 30616579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus-Positive Women and Health Care Practitioners in Tanzania.
    Bateman LB; Blakemore S; Koneru A; Mtesigwa T; McCree R; Lisovicz NF; Aris EA; Yuma S; Mwaiselage JD; Jolly PE
    Oncologist; 2019 Jan; 24(1):69-75. PubMed ID: 29934410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya.
    Mungo C; Ellis GK; Rop M; Zou Y; Omoto J; Rahangdale L
    medRxiv; 2024 Mar; ():. PubMed ID: 38585806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to cervical cancer prevention in rural Cameroon: a qualitative study on healthcare providers' perspective.
    Roux AN; Kenfack B; Ndjalla A; Sormani J; Wisniak A; Tatrai K; Vassilakos P; Petignat P; Schmidt N
    BMJ Open; 2021 Jun; 11(6):e043637. PubMed ID: 34140340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context.
    Adedimeji A; Ajeh R; Pierz A; Nkeng R; Ndenkeh JJ; Fuhngwa N; Nsame D; Nji M; Dzudie A; Anastos KM; Castle PE
    BMC Womens Health; 2021 Feb; 21(1):74. PubMed ID: 33602194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of Screening-Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in Kenya.
    Ragan KR; Buchanan Lunsford N; Lee Smith J; Saraiya M; Aketch M
    Oncologist; 2018 Jan; 23(1):35-43. PubMed ID: 28798272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to and facilitators of smoking cessation in pregnancy and following childbirth: literature review and qualitative study.
    Bauld L; Graham H; Sinclair L; Flemming K; Naughton F; Ford A; McKell J; McCaughan D; Hopewell S; Angus K; Eadie D; Tappin D
    Health Technol Assess; 2017 Jun; 21(36):1-158. PubMed ID: 28661375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to cervical cancer screening uptake among women in Nepal - a qualitative study.
    Greibe Andersen J; Shrestha AD; Gyawali B; Neupane D; Kallestrup P
    Women Health; 2020 Oct; 60(9):963-974. PubMed ID: 32643576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators in antenatal settings to screening and referral of pregnant women who use alcohol or other drugs: A qualitative study of midwives' experience.
    Oni HT; Buultjens M; Blandthorn J; Davis D; Abdel-Latif M; Islam MM
    Midwifery; 2020 Feb; 81():102595. PubMed ID: 31838337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitators and Barriers Affecting Adherence Among People Living With HIV/AIDS: A Qualitative Perspective.
    Ahmed SI; Farooqui M; Syed Sulaiman SA; Hassali MA; Lee CKC
    J Patient Exp; 2019 Mar; 6(1):33-40. PubMed ID: 31236449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.